Monitoring drug treatment
The monitoring of drug treatment availability, accessibility and quality in the Member States is a core task of the EMCDDA. As the evidence base for treatment continues to grow, up-to-date information on effective treatments must be available and easily accessible. This brings new demands on policymakers who need to determine the capacity and performance of national treatment systems and respond to questions such as ‘How many people are in drug treatment?’, ‘Does the existing drug treatment system meet the demand?’, ‘What treatments are offered?’ and ‘Are they effective?’.
Read more »